Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period of March 12, 2018. The company is a foreign private issuer based in Isfiya, Israel, focusing on advanced medical imaging technology.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes
On March 12, 2018, the company announced the initiation of an EU Post Approval Study utilizing its advanced C-Scan system. This represents a significant operational milestone in the regulatory approval process for its technology.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future performance, or a detailed discussion of risks and contingencies beyond the context of the regulatory study. The primary focus is the incorporation of a press release regarding the EU study.
Investor Verification Checklist
- Verify the specific scope and objectives of the EU Post Approval Study for the C-Scan system.
- Confirm the timeline and expected outcomes of the study as detailed in the attached press release (Exhibit 99.1).
- Review the company's recent financial filings (Form 20-F) for the most current liquidity and debt positions, as this 6-K does not contain them.